Fainstein V, Berkey P, Elting L, Bodey G P
Department of Medical Specialities, University of Texas M. D. Anderson Cancer Center, Houston.
Arch Intern Med. 1989 Jun;149(6):1341-5.
We reviewed the clinical and laboratory presentation of Haemophilus species bacteremia at our institution, with special attention to predisposing and prognostic factors. Of 36 cases, 18 presented with pneumonia, 1 with cellulitis, and another with sinusitis. No cases of meningitis or endocarditis were detected. Most episodes were caused by Haemophilus influenzae, and the overall response rate to treatment was 72%. Factors including chronic obstructive pulmonary disease, alcoholism, prior splenectomy, and neutropenia did not play an important role in these patients' infections. Most of the isolates serotyped were found to be nontypable. The occurrence of ampicillin resistance was 6% throughout the study. Ampicillin, chloramphenicol, and second-generation cephalosporins were all effective therapeutic regimens. Bacteremia due to Haemophilus species remains an uncommon infection in patients with cancer, despite the predominance of traditional predisposing factors.
我们回顾了我院嗜血杆菌属菌血症的临床和实验室表现,特别关注了易感因素和预后因素。在36例病例中,18例伴有肺炎,1例伴有蜂窝织炎,另1例伴有鼻窦炎。未检测到脑膜炎或心内膜炎病例。大多数发作由流感嗜血杆菌引起,总体治疗有效率为72%。慢性阻塞性肺疾病、酗酒、既往脾切除术和中性粒细胞减少等因素在这些患者的感染中未起重要作用。大多数分型的分离株为不可分型。在整个研究中,氨苄西林耐药的发生率为6%。氨苄西林、氯霉素和第二代头孢菌素都是有效的治疗方案。尽管存在传统的易感因素,但癌症患者中嗜血杆菌属菌血症仍然是一种罕见的感染。